APIC and NHSN: IPC at Home and Abroad

Dr. Tania Bubb is the Senior Director of Infection Prevention & Control at the Memorial Sloan Kettering Cancer Center in New York, NY. She has worked as an Infection Preventionist since 2006 at major academic medical centers with responsibilities spanning the continuum of care. She’s served her local and national APIC board of directors. Prior to serving at the national level, Dr. Bubb chaired the APIC Professional Development Committee, was a member of the American Journal of Infection Control Editorial Review Board, and a member of APIC’s Practice Resources Editorial Panel.  Most recently, Dr. Bubb co-chaired APIC’s Health Inequities and Disparities Taskforce and is the 2024 APIC President. She is an experienced speaker and author, having presented at local and national APIC events as well as other conferences, and authored publications related to the field of infection prevention and control.

Dr. Bubb received Bachelor and Master of Science Degrees in Nursing from City University of New York Herbert H. Lehman College and earned her Doctor of Philosophy Degree in Nursing from New York University.

Dr. Emily Petersen is a physician and epidemiologist with over a decade of experience in global and US public health surveillance, safe patient care promotion, and emerging infectious diseases response. Dr. Petersen completed her Epidemic Intelligence Service fellowship in 2015, and now works in the International Infection Control Program in the Division of Healthcare Quality Promotion at the U.S. Centers for Disease Control and Prevention (CDC). She is clinically active as an adjust Assistant Professor at the Emory University School of Medicine. Dr. Petersen’s research interests include international public health, maternal and child health, and healthcare-associated infection surveillance.

Dr. Jarrah is a transplant infectious disease physician Staff Physician at KHCC, joining in 2022. Dr. Jarrah completed infectious disease fellowship training at Henry Ford Hospital with transplant infectious diseases and global health experience. He completed his infectious disease fellowship at Wayne State University along with a certificate in Global and Urban Health & Equity. Dr. Jarrah. having completed his fellowship in June 2022 at Henry Ford Health, joined King Hussein Cancer Foundation and Center as a staff physician, and as part of his role at KHCC, is establishing the first structured infectious disease and transplant infectious disease fellowship in Jordan to advance infectious disease training in the Middle East and North Africa Region, to start in summer 2024. His work on improving immunizations  rates in transplant recipients in Metro Detroit region has been recognized on a state and national level. 

Experienced humanitarian manager with a demonstrated history of working with the international non-profit organizations. Skilled in Monitoring and Evaluation, Epidemiology and Health Information Management. I hold a Master of science (M.Sc.) in public health from Jordan University of Science & Technology.

Benedetta Allegranzi is an infectious diseases specialist, with Diplomas in Tropical Medicine and Hygiene (University of Liverpool, UK) and Clinical Research (University of Geneva, Switzerland). From 1994 to 2006, she worked as infectious diseases and infection prevention and control (IPC) specialist and assistant professor at the University of Verona, Italy, as well as in Burundi, Malaysia and some other countries.

She now works at the World Health Organization (WHO) HQ since 2006, as the technical lead of the IPC Hub and the IPC Taskforce and co-lead of the IPC pillar of the WHO response to the COVID-19 pandemic.

Benedetta Allegranzi is also Adjoint Professor at the Global Health Institute and at the Infection Control Programme, Faculty of Medicine, University of Geneva.

With her team, she has provided technical support to many countries in all continents and has led research in the field of health care associated infections, antimicrobial resistance, and IPC; she has been responsible for the development of many new global IPC guidelines and implementation strategies and tools, and two global campaigns on injection safety and hand hygiene (in 182 countries).

She is leading or senior author of 65 WHO official publications, and author or co-author of over 200 scientific publications, and more than 20 book chapters.

Dr. Devin Jopp joined APIC as CEO on December 7, 2020. He brings to APIC more than two decades of association leadership with a wide array of experience and accomplishments from across the healthcare and nonprofit sectors. He has been recognized as one of the top 100 most influential healthcare leaders by Healthcare Management International Magazine and one of the top 50 healthcare IT experts by Health Data Management Magazine. Prior to APIC, he served as CEO for the American College Health Association, the principal leadership organization for advancing the health and well-being of the nation’s 20 million college students and their campus communities through advocacy, education, and research.  He has also previously served as president and CEO for the Workgroup for Electronic Data Interchange (WEDI), a national nonprofit advisor to the Secretary of Health and Human Services focused on enhancing the exchange of healthcare information.  Before joining WEDI, he served as chief operating officer for the Service Corp of Retired Executives, a national nonprofit organization that provides business mentoring and training to American entrepreneurs.   

Melissa Otis is a Nurse Infection Prevention Consultant with the Centers for Disease Control and Prevention (CDC) Division of Healthcare Quality Promotion (DHQP), Surveillance Branch where she is a member of the National Healthcare Safety Network (NHSN) Protocol and Training Team.  In this role, Melissa provides consultation and technical assistance regarding surveillance for healthcare associated infections using NHSN.   She serves as the subject matter expert for the Surgical Site Infection [SSI] surveillance.  Melissa has over 20 years of combined healthcare experience in a variety of leadership roles, many of which focused on Infection Prevention.  She has been a Registered Nurse for over 15 years and earned her Bachelor of Science in Nursing from the University of Illinois at Chicago.

Michelle Fredrick is a Public Health Analyst at Lantana Consulting Group, bringing a wealth of experience from her previous role as a hepatitis epidemiologist. With a robust background in public health, she is experiences with supporting strategic health initiatives to address public health challenges effectively. Her expertise in disease surveillance and outbreak investigation significantly contributes to her current role, where she continues to impact public health through insightful analysis and strategic recommendations. 

Hayley Koslik is an Epidemiologist – Public Health Analyst at Lantana Consulting Group. She supports the CDC’s National Healthcare Safety Network (NHSN) Antimicrobial Use and Resistance (AUR) Module, and provides technical assistance to healthcare facilities submitting data to NHSN. 

Presently, a medical director of Otsuka Manila Research Center.
Holds numerous positions: the chairperson of the HIV/AIDS Core Team (HACT). she is a training officer of the Infectious Disease Section of Makati Medical Center, she is a fellow member of the Philippine Society of Microbiology and Infectious Diseases, a fellow of the Philippine College of Physicians, and a board member of Lingap Para sa Kalusugan ng Sambayanan, a non-governmental health care organization. Additionally, through her affiliation with multiple professional associations over the course of her career, she has served her community with infectious disease resources as a community organizer, consultant, clinician and training officer.

Dr. Aileen A. Lacsamana serves as the Hospital Director of Manila Hospital, a public, municipal, tertiary care facility in Manila. She has spearheaded numerous initiatives aimed at optimizing health care delivery in a public setting. Her advocacy for the hospital’s Infection Prevention and Control and Antimicrobial Stewardship is noteworthy. Beyond her role as Hospital Director, Dr. Lacsamana actively contributes her expertise in public health as a member of the Local Health Board.